|
Re: Resverlogix Announces Publication on Apabetalone in Atherosclerosis Journal
|
8
|
Resverlogix Corp.
|
Nov 28, 2018 09:06AM
|
|
Resverlogix Announces Publication on Apabetalone in Atherosclerosis Journal
|
4
|
Resverlogix Corp.
|
Nov 28, 2018 08:59AM
|
|
2019 Potential Events
|
4
|
Resverlogix Corp.
|
Nov 27, 2018 12:02PM
|
|
Re: What is Mr. Market saying about RVX?
|
3
|
Resverlogix Corp.
|
Nov 26, 2018 03:56PM
|
|
Re: What is Mr. Market saying about RVX?
|
3
|
Resverlogix Corp.
|
Nov 26, 2018 11:25AM
|
|
Re: What is Mr. Market saying about RVX?
|
4
|
Resverlogix Corp.
|
Nov 25, 2018 01:28PM
|
|
BET Inhibition Improves NASH and Liver Fibrosis
|
4
|
Resverlogix Corp.
|
Nov 24, 2018 11:30PM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
5
|
BIOASIS TECHNOLOGIES INC
|
Nov 23, 2018 03:44PM
|
|
Re: Losing exclusivity on Aberatirone may not be all that bad for JNJ or ZEL
|
4
|
Zenith Epigenetics
|
Nov 22, 2018 05:53PM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 21, 2018 10:31AM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
4
|
BIOASIS TECHNOLOGIES INC
|
Nov 21, 2018 10:29AM
|
|
Re: Apabetalone downregulates factors and pathways associated with vascular calcification
|
4
|
Resverlogix Corp.
|
Nov 21, 2018 10:05AM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 21, 2018 10:01AM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 20, 2018 11:00PM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 20, 2018 10:37PM
|
|
Re: Apabetalone downregulates factors and pathways associated with vascular calcification
|
7
|
Resverlogix Corp.
|
Nov 20, 2018 02:21PM
|
|
Apabetalone downregulates factors and pathways associated with vascular calcification
|
6
|
Resverlogix Corp.
|
Nov 20, 2018 10:37AM
|
|
Re: Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
7
|
Zenith Epigenetics
|
Nov 20, 2018 10:29AM
|
|
Re: Zenith and Pfizer collaboration news
|
4
|
Resverlogix Corp.
|
Nov 20, 2018 10:00AM
|
|
Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
|
5
|
Zenith Epigenetics
|
Nov 20, 2018 09:58AM
|
